JAMESFETT
12-08-2007, 07:11 PM
Peripartum Cardiomyopathy (PPCM)
DEFINITION:
1)Onset of heart failure during the last month of pregnancy up to 5 months postpartum (in some the onset may be a month or so earlier or later).
2)No other causes for heart failure.
3)No previous history of heart disease.
4)Echocardiographic evidence of decreased systolic heart function
FREQUENCY:
In the United States, the estimated incidence is between 1 in 2000 to 4000 live births. No precise figure is available because there are no population-based PPCM registries in the USA. In some countries the incidence seems to be higher, such as South African Bantus with an estimated 1 case per 1000 live births, and Haiti with a calculated incidence of 1 case per 350 live births.
CAUSE:
The exact cause of PPCM remains unknown. Leading suspects include viral infections, autoimmune or immune system dysfunction, pregnancy-associated hormones, and genetic factors. Pregnancy-altered hormones, increased heart workload, and immune system changes during pregnancy appear to play a role. However, PPCM can occur in any pregnancy, to mothers of all ages, and in all races.
SYMPTOMS:
Fatigue. Some fatigue is normal with pregnancy and while caring for a new baby, so it's important to know your body and what is out of the norm.
Difficulty breathing. This unusual (for you) shortness of breath may occur with activity or exercise or when lying down.
Swelling. Ankles, feet, hands, and face are all places fluid retention can cause swelling. In severe cases, abdominal swelling may also be present.
Palpitations, or feeling like your heart is racing, stopping, skipping beats, or fluttering.
Unexplained cough. An irritable cough that won’t go away, and not connected with a cold or upper respiratory infection, may be a clue about fluid retention and decreased heart function.
Frequent night time urination. This is from extra fluid accumulating in the legs moving into the circulation while lying down.
Chest Pain. Although not frequent, it is always possible to have chest pain, very mild or more severe. Always seek immediate care for chest pains.
DIAGNOSIS:
Following medical history and physical exam, the most important test is an echocardiogram or ultrasound exam of the heart. It will quickly indicate if there is decreased pumping action (reduced ejection fraction) of the left ventricle and if there is enlargement of the left ventricle, which are the two findings most important in the diagnosis of PPCM. An echocardiogram is absolutely essential if PPCM is suspected.
Other tests, such as electrocardiogram (ECG), chest x-ray, blood tests of cardiac troponin and C-Reactive Protein may be abnormal or normal, and are not diagnostic. Measuring blood B-type Natriuretic Peptide (BNP) is helpful because an elevation indicates stress on the left ventricle and can be used as an indicator of progress in treatment of heart failure.
TREATMENT:
The medications most useful in the treatment of heart failure from PPCM are:
1)Diuretics as needed to decrease excess fluid in the circulation and body tissues, 2)Angiotensin Converting Enzyme-inhibitors (ACE-I) to lower the load on the heart’s pumping action, and 3)Beta-blockade or beta-adrenergic blockers (B-B) to lower afterload and protect against undesirable arrhythmias. The latter two require careful dosage adjustments, starting low to avoid too much lowering of the blood pressure, and very gradually increasing the dosage as tolerated and as needed to help improve the pumping action of the heart. [EXAMPLE (CONSULT YOUR DOCTOR FOR ACTUAL RX & DOSAGE): Start carvedilol (Coreg) at 3.125 mg two times per day; If tolerated by blood pressure not falling and if needed to improve symptoms and heart function (EF determined by echo) increase by steps every two weeks to 6.25 mg, then 12.5 mg, then 15.625 mg, then 18.75 mg, then 21.875 mg, then 25 mg two times per day. When increasing the dose take the first increased level at bedtime in order to minimize any effect on lowered B.P.] Other medications are sometimes needed, such as anticoagulants to avoid blood clots if the left ventricular ejection fraction is below 30 %, spironolactone to help control levels of blood potassium, and digoxin if not responding to the first line medications.
PROGNOSIS:
Almost everyone responds to treatment. Many PPCM patients improve quickly, regaining normal heart function within the first few weeks and months after diagnosis. Others continue to improve over the next several months and years. Even those who do not return to completely normal heart function can improve a great deal with treatment, and live a long, comfortable life. REMEMBER: Healing can continue well beyond the first 6 months after starting treatment, even into the 4th and 5th years; that all dependnds upon how many damaged but salvageable heart muscle cells exist.
Newer, effective treatments have progressively improved survival rates to over 95% and lead to improvement in almost everyone with full recovery of heart function in over 50 % of PPCM patients. Additional evaluations such as cardiac MRI, heart catheterization and endomyocardial biopsy may be necessary for the few patients who are not responding to usual treatment. In a very, very few it may be necessary to consider an implantable cardioverter-defibrillator (ICD) and eventually heart transplant; but that is unlikely to be required.
FUTURE PREGNANCY:
Upon making a full recovery, some women consider the possibility of having another child, and many have experienced a successful subsequent pregnancy. It is important to understand the risks for relapse of heart failure. To learn more about the risks should you consider a subsequent pregnancy, please view the algorithm in the Post-PPCM Baby forum. Also remember that careful monitoring of the subsequent pregnancy is very important in order to diagnose any relapse early and start effective treatment available. We are learning that the lowest risk of relapse of heart failure is associated with PPCM moms who have regained heart function to the level of LVEF 55 % or more and who have adequate contractile reserve on exercise stress echo. Even so, there is never any guarantee that relapse will not occur.
NEW INVESTIGATION: Every new PPCM patient is a candidate to have viral antibodies measured in a blood sample drawn from an arm vein. There are two types of testing to do: 1)IgM (recent infection) and IgG (previous infection) antibodies to Adenovirus, Coxsackievirus, E-B virus, Human herpesvirus 6, Cytomegalovirus, Hepatitis C virus, Parvovirus B19; these are the more common "cardiotropic" viruses. 2)If the IgM antibody test is positive, the Polymerase Chain Reaction (PCR) test for viral particles should be done for that virus.
DEFINITION:
1)Onset of heart failure during the last month of pregnancy up to 5 months postpartum (in some the onset may be a month or so earlier or later).
2)No other causes for heart failure.
3)No previous history of heart disease.
4)Echocardiographic evidence of decreased systolic heart function
FREQUENCY:
In the United States, the estimated incidence is between 1 in 2000 to 4000 live births. No precise figure is available because there are no population-based PPCM registries in the USA. In some countries the incidence seems to be higher, such as South African Bantus with an estimated 1 case per 1000 live births, and Haiti with a calculated incidence of 1 case per 350 live births.
CAUSE:
The exact cause of PPCM remains unknown. Leading suspects include viral infections, autoimmune or immune system dysfunction, pregnancy-associated hormones, and genetic factors. Pregnancy-altered hormones, increased heart workload, and immune system changes during pregnancy appear to play a role. However, PPCM can occur in any pregnancy, to mothers of all ages, and in all races.
SYMPTOMS:
Fatigue. Some fatigue is normal with pregnancy and while caring for a new baby, so it's important to know your body and what is out of the norm.
Difficulty breathing. This unusual (for you) shortness of breath may occur with activity or exercise or when lying down.
Swelling. Ankles, feet, hands, and face are all places fluid retention can cause swelling. In severe cases, abdominal swelling may also be present.
Palpitations, or feeling like your heart is racing, stopping, skipping beats, or fluttering.
Unexplained cough. An irritable cough that won’t go away, and not connected with a cold or upper respiratory infection, may be a clue about fluid retention and decreased heart function.
Frequent night time urination. This is from extra fluid accumulating in the legs moving into the circulation while lying down.
Chest Pain. Although not frequent, it is always possible to have chest pain, very mild or more severe. Always seek immediate care for chest pains.
DIAGNOSIS:
Following medical history and physical exam, the most important test is an echocardiogram or ultrasound exam of the heart. It will quickly indicate if there is decreased pumping action (reduced ejection fraction) of the left ventricle and if there is enlargement of the left ventricle, which are the two findings most important in the diagnosis of PPCM. An echocardiogram is absolutely essential if PPCM is suspected.
Other tests, such as electrocardiogram (ECG), chest x-ray, blood tests of cardiac troponin and C-Reactive Protein may be abnormal or normal, and are not diagnostic. Measuring blood B-type Natriuretic Peptide (BNP) is helpful because an elevation indicates stress on the left ventricle and can be used as an indicator of progress in treatment of heart failure.
TREATMENT:
The medications most useful in the treatment of heart failure from PPCM are:
1)Diuretics as needed to decrease excess fluid in the circulation and body tissues, 2)Angiotensin Converting Enzyme-inhibitors (ACE-I) to lower the load on the heart’s pumping action, and 3)Beta-blockade or beta-adrenergic blockers (B-B) to lower afterload and protect against undesirable arrhythmias. The latter two require careful dosage adjustments, starting low to avoid too much lowering of the blood pressure, and very gradually increasing the dosage as tolerated and as needed to help improve the pumping action of the heart. [EXAMPLE (CONSULT YOUR DOCTOR FOR ACTUAL RX & DOSAGE): Start carvedilol (Coreg) at 3.125 mg two times per day; If tolerated by blood pressure not falling and if needed to improve symptoms and heart function (EF determined by echo) increase by steps every two weeks to 6.25 mg, then 12.5 mg, then 15.625 mg, then 18.75 mg, then 21.875 mg, then 25 mg two times per day. When increasing the dose take the first increased level at bedtime in order to minimize any effect on lowered B.P.] Other medications are sometimes needed, such as anticoagulants to avoid blood clots if the left ventricular ejection fraction is below 30 %, spironolactone to help control levels of blood potassium, and digoxin if not responding to the first line medications.
PROGNOSIS:
Almost everyone responds to treatment. Many PPCM patients improve quickly, regaining normal heart function within the first few weeks and months after diagnosis. Others continue to improve over the next several months and years. Even those who do not return to completely normal heart function can improve a great deal with treatment, and live a long, comfortable life. REMEMBER: Healing can continue well beyond the first 6 months after starting treatment, even into the 4th and 5th years; that all dependnds upon how many damaged but salvageable heart muscle cells exist.
Newer, effective treatments have progressively improved survival rates to over 95% and lead to improvement in almost everyone with full recovery of heart function in over 50 % of PPCM patients. Additional evaluations such as cardiac MRI, heart catheterization and endomyocardial biopsy may be necessary for the few patients who are not responding to usual treatment. In a very, very few it may be necessary to consider an implantable cardioverter-defibrillator (ICD) and eventually heart transplant; but that is unlikely to be required.
FUTURE PREGNANCY:
Upon making a full recovery, some women consider the possibility of having another child, and many have experienced a successful subsequent pregnancy. It is important to understand the risks for relapse of heart failure. To learn more about the risks should you consider a subsequent pregnancy, please view the algorithm in the Post-PPCM Baby forum. Also remember that careful monitoring of the subsequent pregnancy is very important in order to diagnose any relapse early and start effective treatment available. We are learning that the lowest risk of relapse of heart failure is associated with PPCM moms who have regained heart function to the level of LVEF 55 % or more and who have adequate contractile reserve on exercise stress echo. Even so, there is never any guarantee that relapse will not occur.
NEW INVESTIGATION: Every new PPCM patient is a candidate to have viral antibodies measured in a blood sample drawn from an arm vein. There are two types of testing to do: 1)IgM (recent infection) and IgG (previous infection) antibodies to Adenovirus, Coxsackievirus, E-B virus, Human herpesvirus 6, Cytomegalovirus, Hepatitis C virus, Parvovirus B19; these are the more common "cardiotropic" viruses. 2)If the IgM antibody test is positive, the Polymerase Chain Reaction (PCR) test for viral particles should be done for that virus.